Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gillerot, G.
Right arrow Articles by Devuyst, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gillerot, G.
Right arrow Articles by Devuyst, O.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2002) 17: 156-158
© 2002 European Renal Association-European Dialysis and Transplant Association


Interesting Case

Which type of dialysis in patients with cholesterol crystal embolism?

Gaëlle Gillerot1, Christine Sempoux2, Yves Pirson1 and Olivier Devuyst1,

1 Divisions of Nephrology and 2 Pathology, Saint Luc Academic Hospital, Université Catholique de Louvain, Brussels, Belgium

Keywords: anticoagulation; cholesterol crystal; eosinophilia; haemodialysis; peritoneal dialysis

Introduction

Cholesterol crystal embolism (CCE) is an increasingly frequent and potentially severe complication of atherosclerotic vascular disease, resulting from embolization of cholesterol crystals from aortic atherosclerotic plaques to various organs. As recently reviewed [1], CCE may occur spontaneously but is usually triggered by a variety of procedures including arteriography, vascular surgery and anticoagulation—resulting from administration of heparin, low-molecular-weight heparin, oral anticoagulants or thrombolysis [1–3]. The diagnosis of CEE may be challenging because both the clinical picture, which ranges from totally asymptomatic to multisystemic disease, and the laboratory findings lack specificity [1]. Diagnostic clues include risk factors for atherosclerosis, characteristic features such as renal, retinal or cutaneous involvement, and laboratory abnormalities such as hypereosinophilia and hypocomplementaemia [1]. In absence of clinical evidence, histological identification of cholesterol crystals in a target organ remains essential for diagnosis and is the only way to distinguish . . . [Full Text of this Article]

Case

Discussion

Conclusion

Notes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
G. B. Piccoli, E. Maddalena, R. Fenoglio, D. Bilucaglia, E. Mezza, L. Colla, C. Rabbia, and G. P. Segoloni
The long-term dialysis patient with purple-blue toes
Nephrol. Dial. Transplant., July 1, 2006; 21(7): 2022 - 2023.
[Full Text] [PDF]